Evidence map›Paper›PMID 33599562›Full record

ReviewHuman vaccines & immunotherapeutics2022

Vaccination in preterm and low birth weight infants in India.

Santosh Soans, Attila Mihalyi, Valerie Berlaimont, Shafi Kolhapure, Resham Dash, Ashish Agrawal

Open access · hybridAbstract readReview
In one paragraph

Review in Human vaccines & immunotherapeutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Santosh SoansPaediatrics, AJ Institute of Medical Sciences, Mangalore, India.
Attila MihalyiMedical Affairs and Clinical R&D, GSK Vaccines Europe, Wavre, Belgium.
Valerie BerlaimontGlobal Medical Affairs, GSK, Wavre, Belgium.ORCID 0000-0003-3850-4477
Shafi KolhapureMedical Affairs Department, GSK, Mumbai, India.ORCID 0000-0002-3183-1259
Resham DashMedical Affairs Department, GSK, Bengaluru, India.ORCID 0000-0002-0332-5535
Ashish AgrawalMedical Affairs Department, GSK, Hyderabad, India.ORCID 0000-0002-6417-3184
GlaxoSmithKline (India) · INGlaxoSmithKline (Belgium) · BEAssociation for Jewish Studies · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In India, the high neonatal and infant mortality rate is due in part to an increasing number of preterm and low birth weight (LBW) infants. Given the immaturity of immune system, these infants are at an increased risk of hospitalization and mortality from vaccine-preventable diseases (VPDs). In this narrative review, we screened the scientific literature for data on the risk of VPDs, vaccination delay and factors related to it in Indian preterm and LBW infants. Although routine childhood vaccinations are recommended regardless of gestational age or birth weight, vaccination is often delayed. It exposes these infants to a higher risk of infections, their associated complications, and death. After-birth complications, lack of awareness of recommendations, vaccine efficacy and effectiveness and concerns related to safety are some of the common barriers to vaccination. Awareness campaigns might help substantiate the need for (and value of) vaccination in preterm and LBW infants.

Indexed as

Infant, Low Birth WeightInfant, PrematureHumansImmunizationIndiaInfantInfant, NewbornVaccinationimmunizationIndiainfectious diseaselow birth weightNeonatalprematuritypretermvaccination

Identifiers

PMID33599562
PMCPMC8920132
OpenAlexW3130622904

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.